A5360 (MINMON): A Single-arm Study to Evaluate the Feasibility and Efficacy of a Minimal Monitoring Strategy to Deliver Pan-genotypic Ribavirin-free HCV Therapy to Populations Living with HCV Who Are HCV Treatment Naïve with Evidence of Active HCV Infection

Oct 20, 2021